Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 26, 2021 at 07:42 am EDT
Share
Fujian Wanchen Biotechnology Co., Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 247.95 million compared to CNY 327.14 million a year ago. Revenue was CNY 247.95 million compared to CNY 327.14 million a year ago. Net loss was CNY 20.84 million compared to net income of CNY 71.34 million a year ago. Basic loss per share from continuing operations was CNY 0.14 compared to basic earnings per share from continuing operations of CNY 0.62 a year ago. Diluted loss per share from continuing operations was CNY 0.14 compared to diluted earnings per share from continuing operations of CNY 0.62 a year ago.
Fujian Wanchen Biotechnology Group Co Ltd, formerly Fujian Wanchen Biotechnology Co Ltd, is a China-based company mainly engaged in the research and development, factory cultivation and sales of fresh edible fungi. The Company's edible fungi products include enoki mushrooms and real shimeji mushrooms such as crab-flavored mushrooms, white jade mushroom and seafood mushrooms. The Company also distributes bacteria residue. The Company mainly distributes its products within domestic market.